The U.S. healthcare system facilities (hospitals, medical
centers, etc.) are currently owned by anonymous private-equity groups and
various entities from corporate financial industry.
The U.S. healthcare-industrial complex's operations and
transactions (between medical centers, hospitals, pharmaceutical companies,
medical devices and durable equipment manufacturers, insurance companies, and
doctors) tend to be severely underregulated. That lack of the government
regulation and control in in the U.S. health care industry is being maintained
in the same way now as the lack of the government regulation and control has
been in the financial and banking sector.
The culture of that lack of regulation and oversight,
especially with regard to disproportionate pricing, outsize profits, and
excessive compensation, is getting increasingly characteristic of the U.S.
hospitals and medical centers just as in the financial sector.
Drugs and medical equipment producing companies, along with
the major medical facilities (medical centers, hospitals, etc.), have been
freely pursuing their policies of unrestrained prices and profits under the
pretext that it is necessary to fund the risk taking of research and
development. Because of heavy lobbying, Congress prohibits the Centers for
Medicare and Medicaid Services (CMS) of the Department of Health and Human
Services from negotiating prices with drug makers, medical devices and durable
medical equipment manufacturers. It also prevents any legislative measures,
which could be construed as mandates for practice guidelines, coverage
recommendations, payment, or policy recommendations.
The unrestricted freedom of the financial capital in the
U.S. has been turning the nation's healthcare system into another economic
estate of transnational financial corporate oligarchy with serious political
consequences for the United States of America.
The financial sector, which is intrinsically international
in nature, has been tightening its grip on the U.S. healthcare-industrial
complex, using it as another avenue of political influence on the U.S. domestic
policies and more. Hospitals are increasingly consolidating by buying doctors'
practices and competing hospitals. Their position is usually solidified as that
of community's most important charitable institution, and their influential
stakeholders determine economic policies of medical equipment manufacturers,
drug companies, doctors, and rank-and-file employees. As a result, hospitals
have already become the most politically powerful institution in any
congressional district...
The culture of that lack of regulation and oversight,
especially with regard to disproportionate pricing, outsize profits, and
excessive compensation, is getting increasingly characteristic of the U.S.
hospitals and medical centers just as in the financial sector.
Drugs and medical equipment producing companies, along with
the major medical facilities (medical centers, hospitals, etc.), have been
freely pursuing their policies of unrestrained prices and profits under the
pretext that it is necessary to fund the risk taking of research and
development. Because of heavy lobbying, Congress prohibits the Centers for
Medicare and Medicaid Services (CMS) of the Department of Health and Human
Services from negotiating prices with drug makers, medical devices and durable
medical equipment manufacturers. It also prevents any legislative measures,
which could be construed as mandates for practice guidelines, coverage
recommendations, payment, or policy recommendations.
The unrestricted freedom of the financial capital in the U.S.
has been turning the nation's healthcare system into another economic estate of
transnational financial corporate oligarchy with serious political consequences
for the United States of America.
The financial sector, which is intrinsically international
in nature, has been tightening its grip on the U.S. healthcare-industrial
complex, using it as another avenue of political influence on the U.S. domestic
policies and more. Hospitals are increasingly consolidating by buying doctors'
practices and competing hospitals. Their position is usually solidified as that
of community's most important charitable institution, and their influential
stakeholders determine economic policies of medical equipment manufacturers,
drug companies, doctors, and rank-and-file employees. As a result, hospitals
have already become the most politically powerful institution in any
congressional district...
John Oliver, who is a British national, has finally admitted
that, despite the fact that he likes living and working in NYC, if he got ill,
he would rather fly back to the U.K. for treatment than seek medical aid in the
U.S.
That was an unexpected remark but not entirely unusual for
the British comedian, resident in New York, NY. American financial oligarchy,
which undoubtedly is tied to the British corporate finances, currently have
stakes in the U.S. healthcare system. British financiers certainly have an
increasingly greater say in the U.S. healthcare system development. That is not
a purely business domain for the British financiers. The U.S. healthcare system
is being used as another way to influence American domestic politics through
exercising complete command and control of the most powerful political
institution in congressional districts today, i.e. hospitals!
Politicians like Rand Paul work hard to make sure that the
culture of lack of regulation and oversight, prevalent in the banking industry
and financial sector now, would be firmly established in the U.S. healthcare
system as well. In the long run, that would enable the foreign corporate
stakeholders, including those in the U.K., control the political processes
inside the U.S. That is more in the interest of the U.K. than it is in the
interest of the U.S. corporate entities, let alone the ordinary Americans.
That is why any British national, who can think, would
rather support politicians like Rand Paul, who ultimately play into the hands
of foreign (i.e. British) corporate interest groups, than advocate any more
public-oriented healthcare system reform in the U.S. The situation is similar
to that in the financial and banking sector, which the U.S. healthcare system
has already become another political and economic fiefdom of.
No comments:
Post a Comment